Navigation Links
Neurocrine Biosciences to Present at the 27th Annual Piper Jaffray Healthcare Conference
Date:11/25/2015

SAN DIEGO, Nov. 25, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting at the 27th Annual Piper Jaffray Healthcare Conference in New York.

The live presentation takes place on Wednesday, December 2 at 11:00am ET (8:00am PT).  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.  

Listeners are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month.

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders.  The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and NBI-98854, a vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders.  Neurocrine intends to maintain certain commercial rights to its VMAT2 inhibitor for evolution into a fully-integrated pharmaceutical company. 

Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

 


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related biology technology :

1. Neurocrine Biosciences Announces Expansion of its Clinical Pipeline
2. Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results
3. Neurocrine Biosciences to Present at the Barclays Global Healthcare Conference Live Audio Webcast Will be on March 10, 2015
4. Neurocrine Biosciences, Inc. Announces Appointment of Darin Lippoldt as Chief Legal Officer
5. Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon
6. Neurocrine Biosciences To Present At Deutsche Bank 2013 Biofest And The 25th Annual Piper Jaffray Healthcare Conference
7. Neurocrine Biosciences Reports Third Quarter 2013 Results
8. Neurocrine Biosciences Reports Second Quarter 2013 Results
9. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2013 Financial Results
10. Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference
11. Representative Scott Peters Visits Avelas Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2018)... Calif. (PRWEB) , ... September 11, 2018 , ... ... exhibiting at the American Association of Feline Practitioners Conference (AAFP) later ... presenting data on adipose-derived stem cell therapy for the treatment of chronic kidney ...
(Date:9/7/2018)... ... September 05, 2018 , ... Now available on live stream, the NanoScientific Symposium ... 19, 2018. With a panel of industry leaders from Harvard, Cornell, RPI, IBM, SUNY ... insights from experts in the field. Register today to be a part of ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... disease, has been validated to be as effective as manual pathology. The study, ... in Frozen Muscle Biopsies,” was published in the Archives of Pathology & Laboratory ...
(Date:8/31/2018)... ... August 29, 2018 , ... ... both the University of Southampton and the Institute of Industrial Science, the University ... sea can dramatically accelerate the exploration and study of hard to reach deep ...
Breaking Biology Technology:
(Date:9/15/2018)... WAUSAU, Wis. (PRWEB) , ... September 14, 2018 , ... ... improve the rate of clearance of green, blue, and purple tattoo inks - often ... in Surgery and Medicine (LSM), the official journal of the American Society for Laser ...
(Date:9/12/2018)... ... 11, 2018 , ... Tennant Coatings, manufacturer of cutting edge ... of high performance secondary containment coatings, designed to protect substrates in some of ... certified installers with the needed solutions to protect facility’s critical infrastructure and surfaces ...
(Date:9/7/2018)... ... September 05, 2018 , ... ... mAb manufacturing facility late last year, IPS-Integrated Project Services, LLC and G-CON Manufacturing ... autologous cell therapies. The iCON solution provides a pre-fabricated modular cleanroom infrastructure for ...
Breaking Biology News(10 mins):